Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial

Clinical trial NCT00991029 · TERMINATED

Trial details

NCT number: NCT00991029
Sponsor: University of California, San Francisco
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Ischemic Attack, Transient

Start date: 2010-05-28
Primary completion: 2018-04-09
Enrollment: 4881

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.